期刊文献+

Exendin-4对正常动物糖耐量及血糖的影响

Effect of Exendin-4 on the glucose tolerance and serum glucose level in normal animals
下载PDF
导出
摘要 目的:研究Exendin-4对健康动物血糖的影响。方法:Wistar大鼠皮下注射Exendin-4(0.1、0.3、0.9μg/kg),每天给药1次,连续给药4周,分别于首次给药后0、1、2、3、4h及2、4周取血,测定大鼠空腹血糖浓度;ICR小鼠皮下注射Exendin-4(0.2、0.6、1.8μg/kg),15min后灌胃给予2.5g/kg葡萄糖,负荷0.5、1、2、3h后取血,测定血糖浓度;小鼠皮下注射Exendin-4(0.2、0.6、1.8μg/kg),15min后,部分灌胃给予2.5g/kg葡萄糖,5min后取血,测定胰岛素浓度。结果:在给药后不同时间内,Exendin-4组大鼠血糖浓度均未见显著变化。在葡萄糖灌胃后,Exendin-4各给药组小鼠血糖浓度跟对照组比较显著降低。Exendin-4给药组小鼠在葡萄糖负荷后,胰岛素水平有显著升高;而无葡萄糖负荷时,胰岛素水平无统计学差异。结论:Exendin-4刺激胰岛素分泌调节血糖的作用是葡萄糖依赖性的。 AIM: To study the effect of Exendin-4 on the glucose tolerance and serum glucose level in normal animals. METHODS: The fasting blood glu- cose concentration was tested at 0,1,2,3,4 h and 2,4 week after the first administration of Exendin-4 (0.1, 0.3, 0.9 g/kg, 4 weeks, qd) in Wistar rats , taking insulin as positive control. Before intragastric adminis- tration 2.5 g/kg glucose, Exendin-4 (0.2, 0.6, 1.8 g/kg) were subcutaneously injected, then the fasting blood glucose concentration was tested at 0.5, 1, 2 h after the glucose loading. After hypodermic administration of Exendin-4 (0.2, 0.6, 1.8 g/kg), half of the mice were subcutaneously administrated 2.5 g/kg glu- cose 15min later, and the insulin was tested at the end of the experiment. RESULTS: Exendin-4 could not significantly change the fasting blood glucose concen- tration at different times. The fasting blood glucose concentration was significantly decreased after glucose loading by administration Exendin-4. Exendin-4 could increase the serum insulin concentration remarkably after glucose loading and could not change much without glucose loading. CONCLUSION: The results suggest that the blood glucose regulation of Exendin-4 was re- lated to the concentration of glucose.
出处 《中国临床药理学与治疗学》 CAS CSCD 2009年第3期296-299,共4页 Chinese Journal of Clinical Pharmacology and Therapeutics
关键词 EXENDIN-4 血糖 胰岛素 皮下注射 Exendin-4 blood glucose insulin hypodermic injection
  • 相关文献

参考文献10

二级参考文献92

  • 1征革凡,王金平,张辉,胡泽溪,刘娟,肖建中,陈仕明,曹辉碧,李光伟,胡英华,潘孝仁.拜糖平治疗非胰岛素依赖型糖尿病的临床观察[J].中华内分泌代谢杂志,1995,11(3):163-164. 被引量:43
  • 2熊曼琪,朱章志.中医中药治疗非胰岛素依赖型糖尿病必须研究胰岛素抵抗[J].中医杂志,1995,36(1):47-49. 被引量:62
  • 3潘长玉,金文胜.2型糖尿病流行病学[J].中华内分泌代谢杂志,2005,21(5). 被引量:168
  • 4Insucchi SE,Maggs DG,Spollett GR,et al.Efficacy and metabolic effects of troglitazone and metformin in NIDDM[J].Diabetes,1997,46(Suppl 1):34
  • 5Hotta N,K akuta H,K oh N,et al.The effects of acarbose on blood glucose profiles of type 2 diabetic patients receiving insulin therapy[J].Diabetic Med,1993,10:355-358
  • 6Fertig B,Simmons D,Simonson D.Therapy for diabetes[A]//Ha-rris MEd,Bethesda Md.Diabetes in America[M].2nded.National Institutes of Health,NIH Publication No.95-1468,1995:519-534
  • 7Edelman SV,Henry RR.Insulin therapy for normalizing the glycosylated hemoglobin in type II diabetes:application,benefits and risks[J].Diabetes Reviews,1994,3:308-334
  • 8Scheen AJ,Lefebure PJ.Pathophysiology of Type 2 diabetes[A]//Kuhlmann J,PulsW.Handbook of experimental pharmacology:oral antidiabetics[M].Berlin:Springer Verlag,1995:7-42
  • 9Nolan JJ,Ludvik B,Beerdsen P,et al.Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone[J].N Eng J Med,1994,331(18):1188-1193
  • 10Kumar S,Boulton AJM,Beck-Nielsen H,et al.Troglitazone,an insulin action enhancer,improves metabolic control in NIDDM patients[J].Diabetologia,1996,39(6):701-709

共引文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部